July 8, 2010 -- Scientists from the National Institutes of Health discovered the antibodies known as VRCO1 and VRCO2 that prevent most HIV strains from infecting human cells. The find is a potential breakthrough for advancing HIV vaccine design, and antibody therapy for other diseases. Read More